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7ABSTRACT
The purpose of the present study was to find a bioabsorbable polymer with optimal
properties for fixation of osteotomies in rats and rabbits. Two self-reinforced
poly(desamino tyrosyl – tyrosine ethyl ester carbonate), poly(DTE carbonate) or
self-reinforced poly(DTE carbonate)/bioactive glass rods or self-reinforced poly(L/
DL)lactide or self-reinforced poly(L/DL)lactide/bioactive glass rods (2 mm by 26-
40 mm) were implanted into the dorsal subcutaneous tissue and osteotomies of the
distal femur were fixed with these rods (2 mm by 15-26 mm) altogether in 160 rats
and 72 rabbits. The follow-up times varied from one to 52 weeks in rats and from
three to 100 weeks in rabbits. After sacrifice, three-point bending and shear tests
and molecular weight measurements were performed for subcutaneously placed
rods. Radiological, histological, histomorphometrical, microradiographic, and
oxytetracycline-fluorescence studies of the osteotomized and intact control femora
were performed.
The initial mechanical strengths of the SR-P(L/DL)LA (bending 192 MPa and
shear 125 MPa) and SR-P(L/DL)LA/bioactive glass (bending 130 Mpa and shear
94 MPa) rods were higher but they also degraded and lost their mechanical properties
faster than the tyrosine-derived polymers. The polymers containing bioactive glass
retained their properties longer than the plain polymers. Yet, the initial mechanical
strength values of the SR-poly(DTE carbonate)/bioactive glass rods (bending 80
MPa and shear 61 Mpa) were 32-42 % lower than those of the unblended SR-
poly(DTE carbonate) rods (bending 138 MPa and shear 90 MPa), and with SR-
P(L/DL)LA/bioactive glass the values were 25-32 % lower than those of the SR-
P(L/DL)LA rods. The SR-P(L/DL)LA rods had fragmented into pieces at 12 weeks
and the SR-P(L/DL)LA/bioactive glass rods at 48 weeks in vivo, and after that the
mechanical properties could not be measured. At 100 weeks the bending strength
of the SR-poly(DTE carbonate) rods had decreased to 21 % of the initial value and
to 49 % with the SR-poly(DTE carbonate)/bioactive glass rods. The shear strength
had decreased to 10 % with the SR-poly(DTE carbonate) rods and to 23 % of the
initial value with the SR-poly(DTE carbonate)/bioactive glass rods. Most of the
osteotomies healed well, and no signs of osteolysis or foreign-body reactions were
observed. Signs of resorption of the implants were seen at 48 weeks and after that
in the SR-P(L/DL)LA group, at 24 weeks and after that in the SR-P(L/DL)LA/
bioactive glass group, and at 100 weeks in the SR-poly(DTE carbonate)/bioactive
glass group. The SR-P(L/DL)LA/bioactive glass rods were almost totally resorbed
from the bone at 100 weeks.
The present investigation showed that the mechanical strength and fixation
properties of SR-poly(DTE carbonate) and SR-P(L/DL)LA rods with and without
bioactive glass are suitable for fixation of cancellous bone osteotomies in rats and
rabbits and that bioactive glass enhances the biodegradation of the implants.
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The bioabsorbable fixation devices offer certain benefits in the fixation of
osteotomies and fractures compared to the metallic devices. There is no need for a
removal operation, and the stress is gradually released to the healing bone. The
adverse effects of long-term stress shielding on bone provided by metallic devices,
10-20 times as rigid as bone, can be avoided.
During the past decade, bioabsorbable devices have gained popularity in the
internal fixation of fractures and osteotomies (Rokkanen et al. 1985, Rokkanen
1990, Hope et al. 1991, Tunc 1991, Yamamuro et al. 1994, Hofmann 1995, Cordewener
and Schmitz 2000, Rokkanen et al. 2000). According to previous experimental animal
(Vainionpää et al. 1986, Mäkelä et al. 1990) and clinical (Böstman et al. 1987,
Hoffmann et al. 1989) studies, bioabsorbable self-reinforced polyglycolide (SR-PGA)
pins have shown sufficient fixation properties for fixation of cancellous bone
fragments. PGA has a degradation time of a few months (Böstman et al. 1992b).
Previous experimental (Majola et al. 1991) and clinical (Pihlajamäki et al. 1992)
investigations have correspondingly demonstrated safe fixation of small fragment
fractures and osteotomies with self-reinforced poly-l-lactide (SR-PLLA) pins. The
ultimate degradation time of polylactide is several years (Vert et al. 1986, Matsusue
et al. 1995). Despite a slightly weaker initial mechanical strength compared to SR-
PGA pins, the mechanical strength of SR-PLLA pins is maintained at a high level
longer than that of SR-PGA pins (Törmälä 1992).
Previous experimental animal studies have shown that the biocompatibility of
the two most clinically used implants made of bioabsorbable polyesters, polyglycolide
(Herrmann et al. 1970, Frazza and Schmitt 1971, Böstman et al. 1992b) and
polylactide (Kulkarni et al. 1966, Cutright et al. 1971, Matsusue et al. 1995) is
acceptable for internal fixation. The use of intraosseously implanted SR-PLLA
devices does not seem to carry a risk of development of foreign-body reactions
(Bucholz et al. 1994). In previous experimental studies, SR-PGA (Böstman et al.
1992a) and SR-PLLA (Nordström et al. 2001a) implants have been shown to induce
bone formation in the host tissue close to the implant. It has also been shown that a
synthetic material, bioactive glass, could bond to bone developing a chemical bonding
layer on its surface (Hench 1998).
The aim of the present study was to examine the use of self-reinforced
poly(desamino tyrosyl–tyrosine ethyl ester carbonate), poly(DTE carbonate) rods
and SR-poly(L/DL)lactide/bioactive glass composite rods in the fixation of distal
femoral osteotomies in rats as well as the use of SR-poly(DTE carbonate) and SR-
poly(DTE carbonate)/bioactive glass rods and SR-poly(L/DL)lactide 70:30 and SR-
poly(L/DL)lactide 70:30/bioactive glass composite rods in cancellous bone fixation
in the fixation of distal femoral osteotomies in rabbits.
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2. REVIEW OF THE LITERATURE
2.1. Bioabsorbable polymers
Until now the most studied biodegradable polymers for biomedical applications
are polyglycolides (PGA) and polylactides (PLA) which are composed of poly-
alpha-hydroxy acids. These polymers, among others, have been under research since
the 1960’s (Kulkarni et al. 1966, Schmitt and Polistina 1969, Frazza and Schmitt
1971, Cutright and Hunsuck 1972, Reed and Gilding 1981, Vert  et al. 1981, Rokkanen
et al. 1985, Vainionpää 1986, Vihtonen et al. 1987). The SR-PGA implants lose their
mechanical strength in four to eight weeks, which is sufficient for healing of
cancellous bone osteotomies. For cortical bone osteotomy fixation, the SR-PGA
implants lose their tissue-supporting properties too fast, though their initial strengths
exceed those of cortical bone (Vainionpää 1986, Vainionpää et al. 1986). The strength
retention of the SR-PLLA implants was found to be sufficient for fixation of
experimental cortical bone osteotomies in weight-bearing bones (Manninen and
Pohjonen 1993). The first biodegradable fixation devices were manufactured with
melt moulding techniques. The mechanical strengths of the implants were often
insufficient for fixation of osteotomies and fractures. In the late 1970’s self-reinforced
(SR) implants were developed to meet the high strength requirements needed for
secure fixation (Törmälä 1992, Rokkanen and Törmälä 1995).
Tissue reactions to different polymeric biomaterials are often remarkably similar.
The in vivo response is usually characterized by encapsulation of the implant with
fibroblasts, collagen, and inflammatory cells. This response is generally referred to
as a ”foreign-body reaction”. It has also been referred to as an unspecific, material-
chemistry independent response, such as the ”blah” response (Ratner 1993). In
experimental (Weiler et al. 1996) and clinical studies (Böstman et al. 1987) PGA
has been described to cause osteolysis and foreign-body reactions. Earlier it was
assumed that the only possible response at the bone-implant interface was the
formation of a fibrous tissue layer separating the bone from the implant. Later it
has been shown that certain inorganic materials (such as hydroxyapatite and other
calcium phophates, silica based Ca-P containing glasses, and even titanium) can
exhibit direct bone apposition to the implant (Plenk 1998). Most of the synthetic
biodegradable polymers which have been investigated and clinically used as
alternatives to metallic implants (polylactides, polyglycolides, and polydioxanone
etc.) do not exhibit bone apposition but are encapsulated by fibrous tissue (Ertel et
al. 1995, Choueka et al. 1996, Mainil-Varlet et al. 1997). Polyactive®, a copolymer of
poly(ethylene oxide) and poly(butylene terephthalate), has shown direct bone
apposition at the bone-implant interface, probably by inducing the formation of
surface hydroxy carbonate apatite (Radder et al. 1995, Li et al. 1997). In push-out
tests PLLA reinforced with hydroxylapatite and PLLA with a hydroxylapatite
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coating increased interfacial shear strength at three months of implantation
compared to plain PLLA (Verheyen et al. 1993). Hydroxylapatite was not considered
an appropriate material for repairing weight-bearing cortical defects due to its
relatively low mechanical strength but it was found usable in cancellous bone with
fewer mechanical demands (Vuola et al. 1998). Natural coral was studied in bone
defect filling in humans. The coral underwent centripetal resorption, and bone
ingrowth could be observed only in two out of seven biopsies one year after the
operation (Vuola et al.  2000).
2.2.  Polylactide
Polylactide, PLA, a hard and semi-crystalline, high-molecular-weight polymer with
thermoplastic properties, was introduced in 1955 (Schneider 1955). Lactide has two
enantiomeric forms, L-lactide and D-lactide. Two enantiomeric forms of PLA, poly-
L-lactide (PLLA) and poly-D-lactide (PDLA), with opposite configurational
structures are achieved by the ring-polymerization method. PDLA is amorphous,
resulting in a weaker and more rapidly degrading material (Vert et al. 1981, Majola
et al. 1991). Different factors affect the degradation rate, such as molecular weight,
enantiomeric composition of the polymer, size and shape of the implant,
environmental factors, methods of processing, and sterilization (Nakamura et al.
1989). PLLA degrades in the slowest way of the different enantiomeric forms. The
ultimate degradation time of PLLA is several years. Peripheral degradation has
been observed three to four years after implantation (Matsusue et al. 1995). The
copolymer of P(L/DL)LA showed faster degradation in vivo than PLLA after
intramedullary and subcutaneous implantation in rabbits (Majola et al. 1992a,
Suuronen et al. 1992). PLA undergoes hydrolytic de-esterification into lactic acid
which becomes incorporated into the tricarboxylic acid cycle and is mostly excreted
by the lungs as carbon dioxide (Kulkarni et al. 1966, Brandt et al. 1984).
2.2.1. Experimental studies
In experimental studies the biocompatibility of PLA has been good, and no gross
signs of foreign-body reactions have been reported (Cutright et al. 1971, Getter et
al. 1972, Eitenmüller et al. 1987, Bos 1989, Räihä et al. 1990, Majola et al. 1991,
Matsusue et al. 1991, Päivärinta et al. 1993, Bergsma et al. 1996, Nordström et al.
1998, Van der Elst et al. 1999, Nordström et al. 2001a). PLA also seems to have
some osteogenic potential (Hollinger 1983, Schmitz and Hollinger 1988). During a
48-week follow-up intraosseously implanted SR-PLLA screws and pins were shown
to cause similar mild host tissue responses as seen with metallic devices without
signs of inflammatory reactions (Viljanen et al. 1997a). Also, the stress shielding
caused by metallic implants was avoided by using bioabsorbable implants (Viljanen
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et al. 1997b). After a 24- or 52-week follow-up in cancellous bone, no clinical foreign-
body reactions were detected (Peltoniemi et al. 1998, Peltoniemi et al. 1999a). In a
seven-year follow-up, after subcapital femoral osteotomy fixation with SR-PLLA
screws, the biocompatibility was good and the implants were replaced by tight bone.
No other tissue reactions were observed (Jukkala-Partio et al. 2002).
Ultra-high strength PLLA rods implanted in the femoral cavity of rabbits caused
histiocyte activity at 18 months. From 24 to 36 months the activity was at its highest,
and at 62 months the implants were almost totally resorbed, as only a mild residual
tissue reaction could be seen (Matsusue et al. 1995). In another study the tissue
response to PLLA fluctuated as a function of the degree of degradation, exhibiting
an increase in the intensity of inflammation, as the implant began to lose mass
(Hooper et al. 1998). Mandibular osteotomies in sheep fixed with SR-PLLA
multilayer plates were followed-up for five years. The material was almost completely
resorbed, and small particles of polymer were observed at the implantation site.
The foreign-body reaction was mild (Suuronen et al. 1998). The biocompatibility
and the suitability of SR-PLLA miniscrews and plates were shown in the fixation
of frontal bone craniotomies of growing lambs (Peltoniemi et al. 1999b). Cortical
bone osteotomies in rabbits were successfully fixed with intramedullary self-
reinforced fibrillated poly-96L/4D-lactide (SR-PLA96) rods. The implants
disappeared almost totally within three years, and only a minor foreign-body reaction
was observed histologically. For the first 24 weeks the shear strength remained almost
at the initial level, and at 48 weeks there was practically no shear strength left,
which is ideal for the healing bone (Saikku-Bäckström et al. 2001). In another study
cortical bone osteotomies in rabbits were fixed with SR-PLLA rods. After 24 weeks
approximately 25 % of the initial shear strength was left. The fibrillated SR-PLLA
rods were found to be biocompatible and strong enough to be used in the
intramedullary nailing of femoral cortical osteotomies in rabbits (Manninen and
Pohjonen 1993). The combining transforming growth factor-β1 to SR-PLLA rods
seems to enhance bone formation in cancellous bone (Tielinen et al. 1999). The
shear load carrying capacities of cancellous bone, after implantation of SR-PGA
and SR-PLLA pins in the rat femur, were investigated. No osteotomies were done.
The highest values were seen at 36 weeks in both groups. At 52 weeks the SR-PGA
group had significantly higher values than the SR-PLLA group, as the influence of
the SR-PGA pins had ceased. ”Otherwise the shear-load capacities showed higher
values in the SR-PLLA fixed specimens, as the pins carried the load” (Nordström
et al. 2001b). In another study both SR-PGA and SR-PLLA pins seemed to have
good biocompatibility and sufficient fixation properties for internal fixation of
cancellous bone fragments (Nordström et al. 2002). The self-reinforcing and
hydrolytic degradation of  an amorphous poly(ester-amide) (PEA) based on lactic
acid and PLLA were studied and compared in vitro. The degradation of the PEA
rods was significantly faster than that of the PLLA rods. The weight average
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molecular weight of PEA decreased by 90 % of the initial, whereas that of  PLLA
decreased only by 10 % during the first six weeks (Haltia et al. 2002).
SR-poly(L/DL)lactide 70/30 (SR-PLA70) rods were studied in the fixation of
osteotomies of the distal femur and in subcutaneous implantation in rats. At 52
weeks the shear strength of the rods was 41 % of the initial value (121 MPa), and
the flexural strength was 43 % of the initial value (214 MPa). The biocompatibility
and the fixation properties were found promising, as no signs of inflammatory or
foreign-body reactions were observed (Joukainen et al. 2000). The relatively  slow
strength loss rate of the Polypin, made of 70:30 poly(L,DL-lactide), potentially
extends the application of resorbable devices to slow-healing fractures (Claes et al.
1996). Cylindrical implants made of polylactide polymers, bioactive glass, and
Polyactive were used for replacement of intervertebral discs in growing pigs. The
artificial intervertebral discs were able to prevent narrowing of the discectomied
spaces, and tissue regeneration in the spaces was induced (Palmgren et al. 2003).
2.2.2. Clinical studies
PLLA and SR-PLLA fixation devices have been clinically widely used at different
operations with mainly good or excellent results, e.g. in facial fractures and
osteotomies (Roed-Petersen 1974, Bos et al. 1987, Kallela 1999, Ashammakhi et al.
2001) and in ankle fractures and arthrodesis (Partio et al. 1992a, Partio et al. 1992b,
Partio et al. 1992c, Bucholz et al. 1994, Pihlajamäki et al. 1994, Böstman et al. 1995,
Eitenmüller et al. 1996, Hovis et al. 2002). PLLA implants have been used in the
fixation of meniscal lesions (Albrecht-Olsen et al. 1999) and osteochondral fragments
(Matsusue et al. 1996, Tuompo et al. 2000), in anterior cruciate ligament
reconstruction (Tuompo et al. 1999), and in patellar fracture fixation (Juutilainen et
al. 1995). Also femoral neck fractures have been fixed with SR-PLLA screws
(Jukkala-Partio et al. 2000). SR-PLLA fixation devices have also been used in trauma
surgery and in small joint arthrodeses of the hand and foot (Pihlajamäki et al. 1992,
Juutilainen and Pätiälä 1995, Juutilainen et al. 1996). In a study, dislocated ankle
fractures were fixed with SR-PLLA implants. Good or excellent results were
observed in 15 out of 16 patients. In five patients, a mild tissue reaction was observed
(Voutilainen 2002, Voutilainen et al. 2002). Prostatic stents, made of a copolymer
SR-PLGA 80/20, have been used with favourable results (Laaksovirta 2003). The
infection rates between bioabsorbable and metallic fixation devices in orthopaedic
and trauma surgery were compared. There was no significant difference in the
infection rates between the groups (Sinisaari 2004).
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2.3.  Tyrosine-derived polymers
Tyrosine-derived polymers, as well as PLA and PGA, are synthetized from materials
found naturally in the human body. Two distinct backbone structures of tyrosine-
derived polymers have been reported: polycarbonates (Pulapura and Kohn 1992,
Ertel and Kohn 1994) and polyarylates (Fiordeliso et al. 1994). The tyrosine-derived
polycarbonates are amorphous materials that can be processed by solvent casting,
extrusion, compression, and injection moulding, or with various fibre spinning
techniques. As a result, pins with ultimate tensile strength and Young’s Modulus of
50 MPa and 2 GPa, respectively, have been obtained. Tyrosine-derived polymers
have been shown to exhibit minimal cytotoxicity in vitro and support the attachment
and growth of various cell types (Ertel and Kohn 1994, Fiordeliso et al. 1994,
Brocchini et al. 1997).
In vivo degradation, tissue response, and long-term biocompatibility of tyrosine-
derived polycarbonates and polyarylates were investigated. The complete resorption
of poly(DTE carbonate) pins was found to require more than three years which
makes the material most suitable for long-term applications. Also poly(DTE
carbonate) implants maintain their shape longer than PLLA implants, propably
due to the low water uptake. ”While the diphenolic monomers used in the
polycarbonates and polyarylates are identical, the polyarylates are copolymers with
diacids and contain aromatic ester bonds in the backbone that are more labile than
the carbonate bonds of the polycarbonate backbone”. The early onset of physical
disintegration of poly(DTE adipate) pins limited their use to a time period shorter
than 200 days (Hooper et al. 1998). A series of different tyrosine-derived
polycarbonates were evaluated in bone defects and after subcutaneous implantation
in rabbits. Poly(DTE carbonate) retained its strength for the longest period of time,
and, 270 days post implantation, the strength had decreased in a linear fashion to
about 10 % of the initial value. The poly(DTE carbonate) pins still retained their
shape by 1280 days (3.5 years), and only the inside of the implant had become opaque,
as the pins of all other tested polymers had changed shape and become opaque
throughout their entire volume. Poly(DTE carbonate) was also found to elicit ”direct
bone apposition to the implant surface with the highest frequency and would
obviously be a preferred material in the design of orthopaedic implants”. ”Based
on in vivo degradation data and the ability of model polymers with carboxylate
groups at their surface to chelate calcium ions, it is proposed that the ability of
poly(DTE carbonate) to bond to bone is caused by the facile hydrolysis of the
pendent ethyl ester groups which creates calcium ion chelation sites on the polymer
surface” (James et al. 1999). In another study, poly(DTE carbonate) showed a
remarkable degree of direct bone apposition in canine bone chamber models and
”appeared to be comparable, if not superior, to PLA” from a degradation-
biocompatibility perspective (Choueka et al. 1996).
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The above aspects make poly(DTE carbonate) an interesting alternative to widely
used other biodegradable and metallic fixation devices, especially when a long-term
fixation capacity is needed. Tyrosine-derived polycarbonates have not been studied
before in the fixation of osteotomies.
2.4. Bioactive glass
Bioactive glasses are used as bone-graft substitutes with good biocompatibility in
both bone and soft tissue, as the availability of autograft bone is generally limited in
clinical use. Bioactive glasses are composed mainly of silica, sodiumoxide,
calciumoxide, and phosphates. They are surface-active, osteoconductive biomaterials
capable of forming a chemical bond with bone (Hench and Wilson 1984). The first
bioactive glass was developed by Larry Hench in 1967. In 1969 Hench and co-workers
implanted glass in the rat femur and showed a chemical bonding layer of
hydroxyapatite on its surface. This material was named as Bioglass (Hench 1986).
The chemical bonding of bone to the bioactive glass is based on the formation of
a silica-rich hydroxycarbonate apatite layer on the bioactive glass surface (Hench
and Wilson 1984, Hench 1988, Andersson et al. 1990, Andersson and Kangasniemi
1991, Filgueiras et al. 1993, Gatti et al. 1993, Neo et al. 1993). In push-out tests the
strength of the chemical bond between bioactive glass and the host tissue has been
measured to be at least ten times higher than the contact osteogenesis
(osteointegration of titanium) (Andersson et al. 1992). The behaviour of bioactive
glasses is dependent on the composition of the glass (Brink 1997, Brink et al. 1997),
the surrounding pH, the temperature, and the surface layers on the glass (Andersson
et al. 1988, Gatti and Zaffe 1991a). The size of the glass granules also affects the ion
diffusion (Gatti and Zaffe 1991b).
2.4.1. Experimental studies
In experimental cancellous bone defects bioactive glass was found biocompatible,
and the filler effect was greater with bioactive glass than with autogenous bone
(Heikkilä et al. 1995a). The presence of bioactive glass was found to accelerate new
bone formation by allogenic demineralized bone matrix, and the biocompatibility
of the glass was verified by the absence of adverse cellular reactions (Pajamäki et
al. 1993a, Pajamäki et al. 1993b). The microroughening of the bioactive glass surface
significantly enhanced the bone-bonding response, but the glass composition affected
the intensity of the response (Itälä et al. 2003a). In another study the
microroughening of the bioactive glass surface triggered temporal changes in the
expression of specific genes involved in the bone healing process (Itälä et al. 2003b).
Better new bone formation was found in segmental bone defects filled with bioactive
glass granules alone than with a thermoplastic injectable poly(e-caprolactone-co-
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D,L-lactide)/bioactive glass composite (Kukkonen et al. 2001). Earlier
chondrogenesis was found using bioactive glass in experimental subchondral bone
and cartilage repair compared to hydroxyapatite (Suominen et al. 1996).
Only mild inflammatory cell responses to bioactive glasses have been shown in
in vivo studies early in the implantation period (Aho et al. 1993). Bioactive glasses
have been shown to elicit an inflammatory cell response by activating
polymorphonuclear leukocytes and inducing a release of reactive oxygen metabolites
in vitro. The response was found to be related to the durability of the glass (Lindfors
et al. 1999). Also, ”the response of polymorphonuclear leukocytes induced by a
bioactive glass is affected by the proteins in the surrounding solution” (Lindfors
and Klockars 2001). According to in vitro results, the SR-P(L/DL)LA rods containing
bioactive glass showed dimensional stability, neutral degradation, and stronger
apatite formation compared to the plain SR-P(L/DL)LA rods which swell and
released acidic degradation products (Niiranen et al. 2004).
The glasses containing more than 60 mol % SiO2  or with a molar ratio of Ca to
P lower than 5:1 have been reported not to bond to bone (Hench and Wilson 1984,
Hench 1986, Hench 1988). Colonization of osteoblast-like cells producing a
collagenous extracellular matrix has been observed on glass-ionomer bone
substitutes (Brook et al. 1992). Compared to the non-reactive glasses, the stimulatory
effect of bioactive glass on osteoblasts was found ”responsible for a better osteoblast-
like morphology, a higher proliferation rate and generally a better osteoblast
expression” (Vrouwenvelder et al. 1992). Some bioactive glasses can bond to soft
tissues (Hench and Paschall 1973).
2.4.2. Clinical studies
Bioactive glasses have been clinically used for tympanoplastic reconstruction
(Niparko et al. 1988), as filling material in benign tumour surgery (Heikkilä et al.
1995b), for reconstruction of defects in facial bones (Suominen and Kinnunen 1996)
(Suominen 1996), for treatment of periodontal bone defects (Zamet et al. 1997,
Leonetti et al. 2000), in obliteration of frontal sinuses (Suonpää et al. 1997, Peltola
et al. 2000a, Peltola et al. 2000b), in repairing orbital floor fractures (Kinnunen et al.
2000, Aitasalo et al. 2001), in lumbar fusion (Ido et al. 2000), and for reconstruction
of  the iliac crest defect after bone graft harvesting (Asano et al. 1994). The results
have, so far, been promising.
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3. AIMS OF THE PRESENT STUDY
The aims of the present study were to find answers to the following questions:
I. Are the biocompatibility and fixation properties of SR-poly(DTE carbonate)
rods sufficient for fixation of distal femoral osteotomies in rats?
II. Are the biocompatibility and fixation properties of SR-P(L/DL)LA 70:30/
bioactive glass composite rods sufficient for fixation of distal femoral
osteotomies in rats?
III. Are the biocompatibility and fixation properties of SR-poly(DTE carbonate)
and SR-poly(DTE carbonate)/bioactive glass rods sufficient for fixation of
distal femoral osteotomies in rabbits?
IV. Are the biocompatibility and fixation properties of SR-P(L/DL)LA 70:30 and
SR-P(L/DL)LA 70:30/bioactive glass composite rods sufficient for fixation of
distal femoral osteotomies in rabbits?
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4. MATERIALS AND METHODS
4.1. Fixation devices
Self-reinforced poly (desamino tyrosyl - tyrosine ethyl ester carbonate), poly(DTE
carbonate) with a  molecular weight of 146 000 g/mol was supplied by Integra
LifeSciences Corporation (NJ, USA).
Lactide stereocopolymer, poly (L/DL) lactide 70:30 [P(L/DL)LA], Resomer LR
708 (Boehringer Ingelheim, Germany).
Bioactive filler: Crushed (study II; rats) or spherical (studies III and IV; rabbits)
bioactive glass 13-93, particles with composition 6 wt-% Na2O, 12 wt-% K2O, 5 wt-
% MgO, 20 wt-% CaO, 4 wt-% P2O5, 53 wt-% SiO2 (Vivoxid / AbminTechnologies
Ltd, Finland). Particle size distribution was 50-125 µm.
The rods were produced by extrusion (Gimac microextruder, Mac.gi, Italy) and
self-reinforced by solid state die-drawing. The diameter of the finished rods was 2
mm and the length either 15, 26, 36 or 40 mm. The weight percentage of bioactive
glass was 19±2 % (study II) and 15± 1 % (studies III and IV). The rods were sterilized
with gamma irradiation (minimum dose of 25 kGy).
4.2. Experimental animals and anaesthetic procedures
A total of 160 rats and 72 rabbits were used in the present study (Table 1).
Experimental animal care complied with the guidelines of the national law on the
care and use of laboratory animals. The experimental animals were anaesthetized
with subcutaneous injections of medetomidine (Domitor, Orion-Yhtymä Oy, Espoo,
Finland) 0.5 mg/kg (rats) and 0.375 mg/kg (rabbits) s.c. and ketamine (Ketalar, Parke-
Davis, Solna, Sweden) 50 mg/kg (rats) and 25 mg/kg (rabbits) s.c. and diazepam
(Diapam, Orion-Yhtymä Oy, Espoo, Finland) 1.25 mg/kg i.m (only rabbits). During
surgery all experimental animals received benzathin. penicillin and benzylpenicillin
procain (rats 11250 I.U. and rabbits 112500 I.U.) i.m. (Duplocillin LA, Intervet
International B.V., Boxmeer, Holland). The anaesthesia was brought to an end with
atipamezol (Antisedan, Orion-Yhtymä Oy, Espoo, Finland) 0.25 mg/kg (rats only).
The experimental animals received post-operatively buprenorphin (Temgesic,
Reckitt & Colman, Hull, England) 0.0375 mg/kg twice a day for three days.
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Table 1. Number of experimental animals followed up
4.3. Operative technique and postoperative care
4.3.1. Rats; study I [SR-poly(DTE carbonate) rods] and study II [SR-P(L/
DL)LA/bioactive glass rods]
For the strength studies 16 rats in both studies were used (two rats in each follow-
up group). Small areas on both sides of the back were shaved and scrubbed with
antiseptic fluid. The cylindrical rods (2 x 36 mm) were implanted into the dorsal
subcutaneous tissue, and the two incisions were closed in layers.
For the evaluation of the bone fixation properties cylindrical rods (2 x 15 mm)
were used in the fixation of the osteotomies of the distal femur of 64 rats in both
studies (eight rats in each follow-up group). The right hind limb was shaved and
scrubbed with antiseptic fluid, and a medial parapatellar incision was made. The
patella was dislocated laterally, and the articular part of the femur was exposed. A
drill channel of 2 mm in diameter was made from the distal part of the femur through
the cancellous bone. A horizontal osteotomy was made with an oscillating saw in
the cancellous metaphysis of the distal femur. The posterior cortex was broken into
a hinge. After reduction, the osteotomy was fixed with the studied rod, and the
incision was closed in layers (Fig. 1 a-b). The rats were allowed to walk freely in
their cages after the operation, and no external device for immobilization of the
operated limb was used.
Weeks
Rods 1 3 6 12 24 36 48 52 100 Total
Rats
Strength studies 2 2 2 2 2 2 2 2 - 16
SR-poly(DTE carbonate)
Fixation of osteotomy 8 8 8 8 8 8 8 8 - 64
Strength studies 2 2 2 2 2 2 2 2 - 16
SR-P(L/DL)LA/bio-active
glass Fixation of osteotomy 8 8 8 8 8 8 8 8 - 64
Rabbits
SR-poly(DTE carbonate) Fixation and strength
studies






- 3 3 3 3 - 3 - 17
SR-P(L/DL)LA Fixation and strength
studies





- 3 3 3 3 - 3 - 17
Total 20 32 32 32 32 20 32 20 23







4.3.2. Rabbits; study III [SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/
bioactive glass rods] and study IV [SR-P(L/DL)LA and SR-P(L/DL)LA/
bioactive glass rods]
Thirty-six rabbits in both studies were operated on. There were three rabbits in
each follow-up group (except for the 100-week SR-poly(DTEcarbonate)/bioactive
glass and the 100-week SR-P(L/DL)LA/bioactive glass groups with two rabbits only
due to an unexpected death). Small areas on both sides of the back were shaved
and scrubbed with antiseptic fluid. Two cylindrical rods (2 x 40 mm) were implanted
into the dorsal subcutaneous tissue, and the incisions were closed in layers. The
right hind limb was shaved around the knee and scrubbed with antiseptic fluid, and
a medial parapatellar incision was made. The patella was dislocated laterally, and
the articular part of the femur was exposed. Two drill channels of 2 mm in diameter
were made from the postero-distal part of each condyle to the anterior part of the
proximal intercondylar region through the cortex. An osteotomy was made with an
oscillating saw from the antero-distal part of the femoral condyle to the posterior
proximal direction. The posterior cortex was broken into a hinge. After reduction,
the osteotomy was fixed with two rods (2 x 26 mm). The rods were set at the depth
of one millimetre from the articular surface and cut from the anterior surface of the
femur with a saw (Fig. 1 c-d). The incision was closed in layers. The rabbits were
allowed to walk freely in their cages after the operation, and no external device for
immobilization of the operated limb was used.
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Figure 1. (a-d) Schematic anterior and lateral views of the distal rat (a-b) and rabbit
(c-d) femur showing positioning of the osteotomy, the implants, and the four
standardized sample fields (1, 2, 3, 4) used in the histomorphometric analysis.
Fig. 1 a Fig. 1 b
Fig. 1 c Fig. 1 d
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In the study III [rabbits; SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/
bioactive glass rods] most of the rods were thinner than 2 mm in diameter making
the fixation technique difficult. Therefore in most cases a drill of either 1.5 or 1.8
mm in diameter was used to engrave the implant channel suitable for the implant.
Yet the fixation was often loose due to the difficult technique.
4.3.3. The follow-up times
The follow up times in the studies I and II (rats) were one, three, six, 12, 24, 36, 48,
and 52 weeks and in the studies III and IV (rabbits) three, six, 12, 24, 48, and 100
weeks. Two days before sacrifice the experimental animals were given oxytetracycline
(OTC) hydrochloride (Terramycin, Pfizer, Cedex, France) 50 mg/kg intramuscularly
for OTC-labelling studies. The experimental animals were killed with an overdose
of sodium pentobarbital (Mebunat, Orion-Farmos, Turku, Finland) by heart puncture
(rats) and 75 mg/kg i.v. (rabbits). After sacrifice the implants were carefully removed
from the subcutis and immersed in saline until the strength measurements which
were performed within 24 hours.
4.4. Testing of the implant strength properties
The rods were mechanically tested under bending and shear load with a universal
materials tester (Instron 4411, Instron PLC, High Wycombe, England). The three-
point bending test was performed with a crosshead speed of either 5 or 10 mm/min
and a span length either 16 or 32 times the diameter of the sample. The shear strength
test was performed with 10 mm/min according to BS 2782 Method B. The samples
were subjected to the thermal analysis by a differential scanning calorimeter Perkin-
Elmer Pyris 1 DSC (Perkin Elmer, Norwald, USA). The glass transition temperatures
of the samples were determined from the second heating run after quenching. The
retention of the molecular weight during the follow-up period was examined by gel
permeation chromatography (Waters 515 pump and 410 RI detector, Plgel 5 µm
columns, calibration relative to PS-standards, Millennium software, Waters, Milford,
MA, USA). The structures of the polymers were examined with a scanning electron
microscope (SEM, Jeol T100, Tokyo, Japan).
4.5. Tissue sampling techniques
After sacrifice, both femora were taken as specimens with the left femur acting as a
control. Roentgenograms were taken in the anteroposterior and lateral positions
[distance 1.00 m, 35 kV (rats) and 40 kV (rabbits), 3.2 mAs (rats) and 3.6 mAs
(rabbits), 0.03 seconds (rats) and 0.04 seconds (rabbits)]. Macroscopic and manual
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evaluations of the area of the osteotomies were done. The distal portions of both
femora were taken as specimens, fixed in 70 % alcohol, and embedded in
methylmethacrylate. For histologic and histomorphometric analysis, 5-µm
longitudinal sections in the plane of the rods were cut with a Reichert-Jung
microtome (Nussloch, Germany) and stained by the Masson-Goldner method
(Goldner 1938). For contact microradiography (Faxitron X-ray system, Model 43855
A, Hewlett-Packard, McMinnville, Oregon; Imtec Pol-Edged H.R.P., ultra flat, type
1A, Imtec Products, Sunnyvale, California, USA) and oxytetracycline (OTC)
fluorescence studies, 80-µm-thick sections were made with a Leitz Saw Microtome
1600 (Wetzlar, Germany). Fluorescence microscopy was performed using an HBO
220 ultraviolet lamp (Osram, Berlin, Germany) and a BG 812/6 primary filter (Leitz,
Wetzlar, Germany).
4.6. Histomorphometrical analysis
For semiautomatic quantitative histomorphometrical analysis a microscope was
linked via a videocamera  to a computer. Magnifications of 20.6 x and 125 x (studies
I and II), 13.0 x and 78.8 x (studies III and IV) were used. The image analysing
software was AnalySIS (Soft-Imaging Software GmbH, Münster, Germany). Four
specimens (studies I and II) and two specimens (studies III and IV) in all follow-up
groups were analysed. Both femora were analysed in each experimental animal,
the left femur acting as a control. Four standardized sample fields (Fig. 1) were
determined in each femur centralising 6.0 mm from the distal joint level and 1.5
mm apart in the horizontal direction (studies I and II), around the lateral implant
channel 10.0 mm from the distal joint level of the lateral condyle and 1.5 mm apart
in the horizontal direction (studies III and IV). The AnalySIS-program was used in
the determination of the corresponding sample field. Within the 0.68 mm2 (studies
I and II) and 1.57 mm2 (studies III and IV) sample fields, the histomorphometrical
variables were analysed. The variables were as follows: total tissue area, total area
of trabecular bone, total length of the trabecular bone circumference, total length
of the osteoid, and total length of the osteoblast lines.
4.7. Statistical analysis
The paired t-test with one-tailed interpretation was used for statistical evaluation
due to the hypothesis. The hypothesis was that the measured variables in the operated
femora were higher than those in the controls. In addition, the one-way ANOVA




5.1.1. SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/bioactive glass rods
The mechanical properties decreased constantly during the follow-up time. The initial
mechanical strength values for the SR-poly(DTE carbonate) rods containing
bioactive glass were 32-42 % lower than the values of unblended polymer. Yet the
composite structure showed slower degradation of properties, which was unexpected.
In the rats the mechanical strengths of the SR-poly(DTE carbonate) rods
remained high over the one-year period. The shear strength decreased noticeably
faster and was at 52 weeks 73 % of the initial value, while the bending strength
remained practically at the initial level.
In the rabbits the bending strength (Fig. 2 a) of SR-poly(DTE carbonate) rods at
100 weeks had decreased to 21 % and the shear strength (Fig. 2 b) to 10 % of the
initial values (bending 138 MPa and shear 90 MPa). With SR-poly(DTE carbonate)/
bioactive glass rods the bending strength (Fig. 2 a) had decreased only to 79 % at 48
weeks and to 49 % at 100 weeks of the initial values (bending 80 MPa and shear 61
MPa). The shear strength had decreased to 23 % at 100 weeks (Fig. 2 b).
5.1.2. SR-P(L/DL)LA and SR-P(L/DL)LA/bioactive glass rods
The initial mechanical strength values for the SR-P(L/DL)LA rods containing
bioactive glass were 25-32 % lower than the values of unblended polymer. The
composite structure showed slower degradation of properties, as with SR-poly(DTE
carbonate) rods.
In the rats the mechanical strengths of the SR-P(L/DL)LA/bioactive glass rods
could not be measured after 36 weeks. At 24 weeks the shear strength had decreased
to 32 % and the bending strength to 30 % of the initial value.
In the rabbits the SR-P(L/DL)LA rods had fragmented into pieces at 12 weeks
and the mechanical properties could not be measured. The initial bending strength
of the SR-P(L/DL)LA rods was 192 Mpa (Fig. 2 a) and the shear strength 125 Mpa
(Fig. 2 b). With the SR-P(L/DL)LA/bioactive glass rods the bending strength had
decreased only to 61 % (Fig. 2 a) and the shear strength to 50 % (Fig. 2 b) at 24
weeks of the initial values (bending 130 MPa and shear 94 MPa). After that the
mechanical properties of the SR-P(L/DL)LA/bioactive glass rods could not be
measured.
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Figure 2. (a-b) Bending (a) and shear (b) strengths of SR-P(L/DL)LA, SR-P(L/
DL)LA/bioactive glass, SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/
bioactive glass composite rods used for fixation of distal femoral osteotomies in rabbits.
At 12 weeks the SR-P(L/DL)LA and at 48 weeks the SR-P(L/DL)LA/bioactive glass
rods had fragmented into pieces, and the mechanical properties could not be measured.




5.2. Macroscopical, radiological, histological, microradiographical, and OTC-
fluorescence results
5.2.1. Fixation of distal femoral osteotomies with self-reinforced poly(DTE
carbonate) rods in rats (study I)
One of the 64 evaluated osteotomies showed signs of infection at 24 weeks, and
there were five failures of fixation. Fifty-eight osteotomies healed uneventfully. Three
slight displacements were observed radiologically and histologically. No gross signs
of inflammatory or foreign-body reactions were observed. Radiologically the
osteotomy line was visible in most operated femora up to six weeks. At the time of
the operation the rats were still growing, and at the time of the sacrifice the operated
femora were on the average shorter than the controls due to the operation trauma
to the growth cartilage. The callus formation was normal in most cases showing that
the fixation was good. A bony rim around the implants was observed in most cases
after six weeks. In six cases the rod was histologically found broken. In all cases,
except for one where the rod was broken, the fixation was poor at the operation. A
bony rim around the implants was observed in most cases after six weeks.
Microradiographically the new bone was mineralized as normal bone at 12 weeks.
The OTC-uptake was high up to three weeks and lower after that. The
biocompatibility of the SR-poly(DTE carbonate) rods was good, as only a mild
inflammatory tissue reaction to implant was seen.
5.2.2. Fixation of distal femoral osteotomies with self-reinforced poly(L/
DL)lactide 70:30/bioactive glass composite rods in rats (study II)
Thirty-nine out of 64 fixations healed uneventfully and a total of 19 non-unions and
six delayed unions were observed. Three displacements were observed histologically
and radiologically. At 20 operations the fixation was loose and among them 14 non-
unions were observed. There was one infection. No gross signs of inflammatory or
foreign-body reactions were observed. Radiologically the osteotomy line was visible
in most operated femora up to 24 weeks. At the time of the operation the rats were
still growing, and at sacrifice the operated femora were on the average shorter than
the controls due to the operation trauma to the growth cartilage. Strong external
callus formation was seen up to 12 weeks. A bony rim around the implants was
observed in most cases after six weeks. Microradiographically the new bone was
mineralized like normal bone at 12 weeks. The OTC-uptake was high up to six weeks
and at 12 weeks it was only moderate. The biocompatibility of the SR-P(L/DL)LA/
bioactive glass composite rods was good, as only a mild inflammatory tissue reaction
was seen.
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5.2.3. Fixation of distal femoral osteotomies with self-reinforced poly(DTE
carbonate) and self-reinforced poly(DTE carbonate)/bioactive glass rods in
rabbits (study III)
In the macroscopic evaluation after sacrifice the operated femora seemed relatively
good, and no significant shortening of the operated femora was seen. There was
one patellar luxation in both groups. The rabbits used both of their legs normally
after three weeks from the operation. Radiologically (Fig. 3 a-b) the osteotomy line
was visible in most operated femora up to three weeks in the SR-poly(DTE
carbonate) group and up to six weeks in the SR-poly(DTE carbonate)/bioactive
glass group. At six weeks and after that a bony rim around the implant was seen in
all cases (Figs. 4 a-b, 5 a-b, 6 a-b). Slight external callus formation was seen at three
weeks in the SR-poly(DTE carbonate) group and up to six weeks in the SR-
poly(DTE carbonate)/bioactive glass group. The OTC-results showed that healing
had occurred within the normal time and active osteoid formation was slow after
six weeks. The rods were found broken at the site of the osteotomy in two cases in
the SR-poly(DTE carbonate) group and in three cases in the SR-poly(DTE
carbonate)/bioactive glass group, though there was only one failure of fixation in
both groups. In the SR-poly(DTE carbonate)/bioactive glass group signs of
degradation of the implant and new bone formation in the implant channel were
seen after 100 weeks of the follow-up (Fig. 7 a-b). This was not observed in the SR-
poly(DTE carbonate) group.
5.2.4. Fixation of distal femoral osteotomies with self-reinforced poly(L/
DL)lactide 70:30 and self-reinforced poly(L/DL)lactide 70:30/bioactive glass
composite rods in rabbits (study IV)
Most osteotomies healed well, and no gross signs of inflammatory reactions were
observed. One slight displacement in the three-week follow-up group and one non-
union in the 12-week follow-up group were seen with SR-P(L/DL)LA rods. No
significant shortening of the operated femora was seen. The rabbits used both of
their legs normally after three weeks from the operation. Radiologically (Fig. 3 c-d)
the osteotomy line was visible in most operated femora up to three weeks in both
groups. At six weeks and after that a bony rim around the implant was seen in all
cases (Figs. 4 c-d, 5 c-d, 6 c-d). In one case the rods were found histologically broken
at the site of the osteotomy in the SR-P(L/DL)LA group. Signs of resorption of the
implants were seen after 48 weeks in the SR-P(L/DL)LA group and after 24 weeks
in the SR-P(L/DL)LA/bioactive glass group (Fig. 7 c-d). The SR-P(L/DL)LA/
bioactive glass rods were almost totally resorbed from the bone at 100 weeks.
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Figure 3. (a-d) In the radiographs (48 weeks; rabbits) after fixation with SR-poly(DTE
carbonate) (a), SR-poly(DTE carbonate)/bioactive glass (b), SR-P(L/DL)LA (c),
and SR-P(L/DL)LA/bioactive glass rods (d) the healing of the osteotomy can be
seen. The osteotomy lines are not visible. The implant channels (white arrow) and the
bony rims around them can be seen well, especially with PLA derived rods. The control






Figure 4. (a-d) Photomicrographs 1 mm proximally to the osteotomized site in rabbits
at three weeks after fixing with SR-poly(DTE carbonate) (a), SR-poly(DTE
carbonate)/bioactive glass (b), SR-P(L/DL)LA (c), and SR-P(L/DL)LA/bioactive
glass (d) rods. The implant channel on the top. The bony rim around the implant
channel is seen (white star). No gross signs of  inflammatory reactions can be seen.







Figure 5. (a-d) Photomicrographs of the osteotomized site at six weeks in rabbits
after fixing with SR-poly(DTE carbonate) (a), SR-poly(DTE carbonate)/bioactive
glass (b), SR-P(L/DL)LA (c), and SR-P(L/DL)LA/bioactive glass (d) rods. The
implant channel on the top. The bony rim around the implant channel is seen (white
star). No gross signs of  inflammatory reactions can be seen. The osteoblast activity is






Figure 6. (a-d) Microradiographs of the osteotomized site at 12 weeks in rabbits
after fixing with SR-poly(DTE carbonate) (a), SR-poly(DTE carbonate)/bioactive
glass (b), SR-P(L/DL)LA (c), and SR-P(L/DL)LA/bioactive glass (d) rods. The
osteotomies are consolidated. The bony rims (white arrow) around the implant
channels (white stars) and the bioactive glass granules (b and d) are clearly seen.






Figure 7. (a-d) OTC-fluorescence pictures of the medial condyles at 100 weeks in
rabbits after fixing with SR-poly(DTE carbonate) (a), SR-poly(DTE carbonate)/
bioactive glass (b), SR-P(L/DL)LA (c), and SR-P(L/DL)LA/bioactive glass (d) rods.
Signs of peripheral bone formation around the SR-poly(DTE carbonate)/bioactive
glass rods can be seen (b). The PLA-derived rods (c and d) have resorbed almost
totally, and there is new bone in the implant channels (white star). The OTC-activity







At three weeks the osteoblast activity with SR-poly(DTE carbonate)-based rods
was higher compared to that with SR-P(L/DL)LA-based rods. Also, in the rabbits,
the osteoblast activity was higher in the groups containing bioactive glass compared
to the groups with the same polymer without bioactive glass. At six weeks and after
that the differencies between the groups were smaller. The mean total trabecular
bone area fraction in the operated femora was higher than that in the control femora
in all follow-up groups, except for the 100-week groups in the study IV. The
differences between the groups were not statistically significant (Table 2).
Table 2. The difference in the total osteoblast line lenght fractions between the operated








Weeks Mean SD Mean SD Mean SD Mean SD
3 1.39 (1.68) < 1.85 (1.75) 0.75 (0.56) < 1.27 (1.13)
6 0.30 (0.30) 0.20 (0.33) 0.27 (0.24) < 0.47 (0.74)
12 0.01 (0.02) < 0.03 (0.07) 0.05 (0.10) < 0.08 (0.11)
24 0.00 (0.00) = 0.00 (0.00) 0.02 (0.05) 0.00 (0.00)
(paired t-test with one-tailed interpretation, n=8, ns)
The trabecular bone circumference fraction and the osteoblast line length fraction
in the operated femora had a tendency to start from high values and to descend to
the end-stage level at around 12 weeks [SR-poly(DTE carbonate)/bioactive glass,
SR-P(L/DL)LA and SR-P(L/DL)LA/bioactive glass rods in rabbits] and 24 weeks
[SR-poly(DTE carbonate) and SR-P(L/DL)LA/bioactive glass rods in rats and SR-
poly(DTE carbonate) in rabbits].
The tyrosine-derived rods showed higher values, and the rods containing bioactive
glass seemed to enhance the activity of bone formation. A  statistically significant
difference was found in the rabbits at 12 weeks in the differences of the total
trabecular bone circumference fractions between the operated and control femora
compared to the other groups (Table 3; n=8, p<0.05).
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Table 3.  The difference in the total trabecular bone circumference fractions between
the operated and control femora in rabbits at 12 weeks (mean and SD). Higher values
can be seen with the tyrosine-derived rods. Bioactive glass seems to enhance bone
formation.
In the rabbits the binomial sign test showed significant differencies between the
groups containing bioactive glass compared to the groups without bioactive glass
(Table 4; n=31, p<0.025), thus proving that the bioactive glass actually does enhance
the bone formation.
Table 4. Binomial sign test showing the effect of bioactive glass. The number of values
when higher with bioactive glass compared to values higher without bioactive glass
(all follow-up times added together).
Rods Mean SD
SR-poly(DTE carbonate) 1.789 (1.138)
SR-poly(DTE carbonate)/bioactive glass 1.979 (1.795)
SR-P(L/DL)LA 0.248 (1.113)
SR-P(L/DL)LA/bioactive glass 0.408 (0.661)
(one-way ANOVA, n=8, p<0.05)
Variable
Total trabecular bone area fraction 7:1 p<0.05
Total trabecular bone circumference fraction 5:3 ns
Total osteoid length fraction 5:3 ns
Total osteoblast line length fraction 5:2 ns
All 22:9 p<0.025




The ideal device for osteosynthesis provides fixation capacity for a certain period
of time depending on the application and then disappears slowly releasing the stress
to the healing bone. The need for a removal operation should be avoided, too. The
bioabsorbable fixation devices have been developed to meet these standards.
Lately bioabsorbable devices have been increasingly used in the fixation of
fractures and osteotomies (Rokkanen et al. 1985, Rokkanen 1990, Hope et al. 1991,
Tunc 1991, Yamamuro et al. 1994, Hofmann 1995, Cordewener and Schmitz 2000,
Rokkanen et al. 2000). In experimental animal (Vainionpää et al. 1986, Mäkelä et
al. 1990) and clinical (Böstman et al. 1987, Hoffmann et al. 1989) studies,
bioabsorbable PGA and SR-PGA pins have shown sufficient fixation properties in
the fixation of cancellous bone fragments. Previous experimental (Majola et al. 1991)
and clinical (Pihlajamäki et al. 1992) investigations have correspondingly
demonstrated safe fixation of small fragment fractures and osteotomies with self-
reinforced poly-l-lactide (SR-PLLA) pins. The degradation time of PGA is only a
few months (Böstman et al. 1992b), while that of PLA is several years (Vert et al.
1986, Matsusue et al. 1995). Despite a slightly weaker initial mechanical strength
compared to SR-PGA pins, the mechanical strength of SR-PLLA pins is maintained
at a high level significantly longer than that of SR-PGA pins (Törmälä 1992).
The aim of the present study was to examine the use of SR-poly(DTE carbonate)
and SR-poly(DTE carbonate)/bioactive glass rods and SR-P(L/DL)lactide 70:30
and SR-P(L/DL)lactide 70:30/bioactive glass composite rods in cancellous bone
fixation in the fixation of distal femoral osteotomies in rats and rabbits.
At the time of the operation the rats were still growing, and at sacrifice the
operated femora were on the average shorter than the controls due to the operative
trauma to the growth cartilage. In the rabbits no shortening of the operated femora
was observed. In most cases the callus formation was normal, showing that the
fixation was good. The histomorphometric and oxytetracycline bone labelling results
showed that the healing occurred within normal time, and the active osteoid
formation was slow after six weeks in all groups. The activity of bone formation was
higher with tyrosine-based rods than with PLA-based rods. Also, the rods containing
bioactive glass showed higher bone formation activity compared to the same
polymers without bioactive glass.
Most of the SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/bioactive
glass rods used in the rabbits (study III) were thinner than 2 mm in diameter making
a rigid fixation difficult. This indicates that the inadequate operative technique may
have affected the results. Also, the operation technique used in the rats was more
difficult than that in the rabbits. A proper technique for a rigid fixation is necessary
for good results with all materials.
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The SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/bioactive glass rods
lost their mechanical strengths slowly, and the strengths could still be measured at
100 weeks. In the SR-poly(DTE carbonate)/bioactive glass group signs of
degradation of the implant and new bone formation in the implant channel were
seen at 100 weeks. This was not observed in the SR-poly(DTE carbonate) group.
The P(L/DL)LA-based rods lost their mechanical strengths and resorbed from the
bone much faster than the tyrosine-based rods. The initial  mechanical strengths of
the rods containing bioactive glass were lower than those of the plain polymer rods.
Yet, the composite rods maintained their mechanical strength longer than the plain
polymer rods. At 100 weeks the SR-P(L/DL)LA/bioactive glass rods were almost
totally resorbed from the bone. The difference in degradation after addition of
bioactive glass, known to degrade readily under physiological conditions, can be
explained by the closed structure of the composite. The volume fraction of the glass
was low, and the particles were completely surrounded by the polymer. However, in
both polymers, the porous structure of the rods containing bioactive glass allowed
the bone to penetrate into the implant faster, and also the rods seemed to disappear
faster from the bone. It seemed that the exposure of the rods to the mechanical
forces and to the active, healing bone tissue after osteotomy resulted in a more
rapid degradation than what was seen in the subcutaneous tissue.
Previous experimental animal studies have shown that the biocompatibility of
the two most clinically used implants made of bioabsorbable polyester, polyglycolide
(Herrmann et al. 1970, Frazza and Schmitt 1971, Böstman et al. 1992b) and
polylactide (Kulkarni et al. 1966, Cutright et al. 1971, Matsusue et al. 1995), is
acceptable for internal fixation. The use of intraosseously implanted SR-PLLA
devices does not seem to carry risks for development of foreign-body reactions
(Bucholz et al. 1994). In a previous study, with follow-up times of 20-250 days, the
histomorphometrical analysis of the tissue-implant interface showed the osteogenic
response to PGA to be vigorous but transitory after internal fixation of a rabbit
distal femoral osteotomy with a PGA screw (Böstman et al. 1992a). In another
study, no signs of degradation of SR-PLLA pins were observed within the 52-week
follow-up times, but the total bioabsorption of SR-PGA pins had occurred between
the follow-up periods of 24 and 36 weeks (Nordström et al. 1998). In the earlier
literature only one late foreing-body reaction to high-molecular-weight PLLA has
been reported in an experimental study in one single rat followed up for a
considerably longer time than the other rats (Bos et al. 1991).
Foreign-body reactions and osteolysis are often observed with PGA due to the
rapid degradation (Weiler et al. 1996). In one study, no clinically relevant
inflammation was observed due to the slow degradation process of poly-L-DL-
lactide pins (Prokop et al. 2004). In another study the difference between poly(DTE
carbonate) and PLLA was observed, as ”the tissue response to PLLA fluctuated as
a function of the degree of degradation, exhibiting an increase in the intensity of
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inflammation as the implant began to lose mass” (Hooper et al. 1998). Also, ”from
a degradation-biocompatibility perspective, the tyrosine-derived polycarbonates
appear to be comparable, if not superior, to PLA” (Choueka et al. 1996). In this
study no signs of osteolysis or foreign-body reactions were observed in any of the
groups. The absorption of water is slower with the tyrosine-derived polymers than
with most other biopolymers, which is one cause for the slow rate of degradation of
tyrosine-derived polymers.
Tyrosine-derived polycarbonates and bioactive glass have been earlier used mostly
in the reconstruction of bone defects (Heikkilä et al. 1995b, Suominen et al. 1996,
James et al. 1999). The present study is the first to use tyrosine-derived polycarbonate
and bioactive glass in the fixation of osteotomies in rats and rabbits. The tyrosine-
derived polycarbonates, especially poly(DTE carbonate), have shown interesting
characteristics in previous studies. A direct bone-bonding ability has been shown in
experimental studies (Choueka et al. 1996, James et al. 1999). Minimal cytotoxicity
in vitro and supporting the attachment and growth of various cell types has been
shown in studies with tyrosine-derived polymers (Ertel and Kohn. 1994, Fiordeliso
et al. 1994, Brocchini et al. 1997). ”Based on in vivo degradation and the ability of
model polymers with carboxylate groups at their surface to chelate calcium ions, it
is suggested that the ability of poly(DTE carbonate) to bond to bone is caused by
the facile hydrolysis of the pendent ethyl ester groups which create calcium ion
chelation sites on the polymer surface” (James et al. 1999). This was not, however,
observed with certainty in the present study. On the contrary, the bone and connective
tissue rim seem to be the bone-tissue response to injury and operation trauma.
Using the operated limb causes torque and micro movement between the implant
and bone, which increases granulation tissue production. Also, the specimens were
fixed with alcohol after sacrifice, which caused the tyrosine-based rods to melt and
come out of the implant channels. This made studying the bone-bonding ability
impossible in the present study.
A previous investigation demonstrated that the mechanical strength and fixation
properties of the SR-poly(L/DL)lactide rods are suitable for fixation of cancellous
bone osteotomies in rats (Joukainen et al. 2000). There have been no significant
differencies between the experimental studies on rats or rabbits when using the
same fixation devices. In another previous study the fixation properties of both SR-
PLLA pins and metallic Kirschner wires were found to be sufficient for fixation of
small cancellous bone fragments, but, by using SR-PLLA pins instead of Kirschner
wires, the second operation for removal of the implants could be avoided (Viljanen
et al. 1997a). In another study, osteotomies of the distal femur in rabbits were
successfully fixed with two 1.5 mm thick SR-PGA and SR-PLLA rods (Manninen
et al. 1992). The initial bending strength of SR-PLLA rods was in another study
250-271 MPa and the shear strength 94-98 MPa. The initial bending strength of SR-
PDLLA/PLLA implants was 209 MPa (Majola et al. 1992a).
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Compared to the other bioabsorbable polymers studied previously, the SR-
poly(DTE carbonate) and SR-poly(DTE carbonate)/bioactive glass rods retain their
mechanical properties for a longer period of time. The initial bending strength of
SR-poly(DTE carbonate) rods used in this study was 138 Mpa and the initial shear
strength 90 MPa which are lower than those of SR-PLLA and SR-PGA. The addition
of bioactive glass results in weaker initial mechanical strengths but enhances the
biodegradation of the implant. Also in previous studies, tyrosine-derived polymers
and bioactive glasses have shown a bone-bonding ability which makes them an
interesting alternative to the bioabsorbable polymers used clinically so far. The SR-
P(L/DL)LA 70:30 rods used in this study, with the initial bending strength of 192
Mpa and shear strength of 125 MPa, lose their mechanical strengths rapidly and
offer fixation capacity only for about six weeks, as SR-P(L/DL)LA 70:30/bioactive
glass rods offer fixation capacity up to 24 weeks.
The results of in vivo and in vitro material studies suggest that the biocompatibility
and mechanical properties of SR-poly(DTE carbonate), SR-poly(DTE carbonate)/
bioactive glass, SR-poly(L/DL)lactide 70:30, and SR-poly(L/DL)lactide 70:30/
bioactive glass rods are suitable for cancellous bone fracture fixation in rats and
rabbits and that the bioactive glass enhances the biodegradation of the implants.
According to the results of the present study, it is assumed that the fixation devices
made of SR-poly(DTE carbonate) and SR-poly(DTE carbonate)/bioactive glass
could be clinically used for fracture fixation applications where a fixation capacity
of several months is needed. Devices made of SR-P(L/DL)LA 70:30 could be
applicable in rapidly healing fractures and osteotomies when a fixation capacity of
only about six weeks is needed and devices of SR-P(L/DL)LA 70:30/bioactive glass
when a fixation capacity of 12 weeks is necessary.
PLLA is presently widely used in clinical applications. The most common
applications of bioabsorbable devices in fracture fixation have been fresh fractures
of the humeral condyles, olecranon, radial head, carpal and metacarpal bones, distal
femur, proximal tibia, and, particularly, fractures of the ankle. Osteotomies and
arthrodeses in the hand and foot have also often been fixed with bioabsorbable
devices. Several different kinds of fixation devices have been developed and made
of polylactides. For example, tacks and arrows are especially suitable for mini-
invasive arthroscopical purposes.
Weight-bearing cortical bone fixation in humans is a challenging objective for
further application of biodegradable devices. Successful experimental cortical bone
fixations with intramedullary polylactide rods have been described (Majola et al.
1992b, Manninen and Pohjonen 1993,  Hara et al. 1994, Viljanen et al. 1998, Saikku-
Bäckström et al. 2001). The requirements for the devices in cortical bone fixation
are a high initial mechanical strength and a sufficiently long retention of the
mechanical properties in order to allow the slowly healing cortical bone osteotomy
or fracture to heal. The initial mechanical strength values of SR-poly(DTE
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carbonate) are lower than those of SR-PLLA, but SR-poly(DTE carbonate) seems
to retain its mechanical properties longer.
In the future bioabsorbable polymers will most propably replace most of the
traditional metallic and biostable polymer devices in surgical applications where
only a temporary presence of the device is needed. Also physiologically active
components, which facilitate the healing or form constituents of healing tissues, can
be added to the bioabsorbable devices (Tielinen et al. 1999). The combining of
material- and biotechnology with medicine in order to develop synthetic devices,
which will be transformed into living, functional tissues and organs, such as bone,
cartilage, tendons or ligaments, provides a promising prospect for the future




On the basis of the present study, the following conclusions can be drawn:
I. The biocompatibility and mechanical properties of SR-poly(DTE carbonate)
rods are suitable for cancellous bone fracture fixation in rats.
II. The biocompatibility and mechanical properties of SR-poly(L/DL)lactide
70:30/bioactive glass rods are suitable for cancellous bone fracture fixation in
rats.
III. The biocompatibility and mechanical properties of SR-poly(DTE carbonate)
and SR-poly(DTE carbonate)/bioactive glass rods are suitable for cancellous
bone fracture fixation in rabbits, and the addition of bioactive glass enhances
the biodegradation of the implants.
IV. The biocompatibility and mechanical properties of SR-poly(L/DL)lactide and
SR-poly(L/DL)lactide/bioactive glass rods are suitable for cancellous bone
fracture fixation in rabbits, and the addition of bioactive glass enhances the
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